Learn how Dupixent helps diverse eczema patients and why inclusive clinical trials are vital for fair healthcare.

Spongiotic dermatitis describes skin inflammation that causes swelling, redness, and itching. It's most often associated with ...

Nektar, which accused Lilly of making errors in its analysis of the data, forged ahead with the programme and started the ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

Nektar’s shares have surged more than twofold after a Phase IIb study of its atopic dermatitis (AD) therapy rezpegaldesleukin ...

Discover life-changing eczema treatments and remedies that provide real relief. From prescription breakthroughs to natural ...

Medically reviewed by William Truswell, MD Eczema is a long-term condition where an overactive immune response causes skin inflammation (swelling) and irritation. Eczema leads to dry, itchy patches of ...

Blujepa: Most recently, the U.S. Food and Drug Administration (FDA) approved Blujepa (gepotidacin), the first of a new class of drugs for the treatment of uncomplicated urinary tract infections caused ...

Please provide your email address to receive an email when new articles are posted on . Chronic low back pain is one of the most frequent and challenging conditions encountered in primary care ...

Also last week, we learned that the FDA will review a new oral antibiotic for gonorrhea called dolophrosyne. If it's approved, it would be the first new antibiotic for gonorrhea in decades. Todd, this ...

The Calibr-Skaggs Institute for Innovative Medicines, the drug development division of Scripps Research, today announced a milestone in cancer treatment with the dosing of the first patient in a ...

A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting compared to clinical trials.